The important role of cells of the macrophagehistiocyte series in host defence against infection and cancer is now recognized. Murine alveolar macrophages (AMq,) obtained by lavage from normal healthy donors are usually not cytotoxic to tumour cells in vitro . These noncytotoxic AMq, however, can be rendered tumoricidal by interaction in vitro with bacterial products, or lymphokines . AM? can also be activated to kill tumour cells by in vivo treatment with preparations of bacteria such as Bacillus Calmette-Guerin, Corynebacterium parvum, or cell wall skeletons of Nocardia rubra (Olivotto & Bomford, 1974; Sone & Fidler, 1982; Zwilling & Campolito, 1977) . The resultant cytotoxic AM? should function as primary effector cells against tumours growing in the lung. In fact, there is encouraging evidence of a close association of the tumoricidal activities of AM? and eradication of pulmonary metastasis in mice Sone & Fidler, 1982) .
Vitamin A and its analogues are known to have antitumour activity against chemical carcinogeninduced or transplanted tumours (Bollag, 1971; Kurata & Micksche, 1977; Moon et al., 1976; Nettesheim & Williams, 1976; Saffioti et al., 1967; Seifter et al., 1983) . There is some evidence that certain retinoids stimulate immune responses: Vitamin A stimulates the induction of cell-mediated cytotoxicity against tumours (Dennert & Lotan, 1978; Dennert et al., 1979; , enhances natural killer cell activity (Goldfarb & Herberman, 1981), accelerates graft rejection (Floersheim & Bollag, 1972) , augments lymphocyte blastogenesis (Abb & Deinhardt, 1980; Lapin et al., 1974; Micksche et al., 1977) , and potentiates the antitumour effect of BCG vaccine (Kurata & Micksche, 1977) . Retinoids also seem to stimulate the function of the mononuclear phagocyte system, since they have been found to augment defence activity against infection with Listeria monocytogenes (Hof & Emmerling, 1980) . These findings suggest that the antitumour effect of vitamin A and its analogues might be mediated indirectly via enhancement of host defence activities. Little is known about activation and/or potentiation of tumoricidal macrophages by vitamin A or its analogues. AM(p may be important in host defence against neoplastic cells developing and/or growing in the lung. Since the lung is often used to evaluate the inhibitory effect of vitamin A on chemical carcinogenesis (Nettesheim & Williams, 1976; Saffioti et al., 1967) , it seemed of interest to determine whether vitamin A could activate AM? to destroy syngeneic tumour cells.
In this paper, we report that AM<p from F344 rats can be rendered cytotoxic to syngeneic tumour cells by incubation in vitro with retinyl palmitate, and also by oral administration of vitamin A to 1 344 rats for 4 days.
Materials and methods

Animals
Specific pathogen-free inbred F344 male rats of 5-7 weeks old were obtained from the Shizuoka Animal Facility Center (Shizuoka, Japan). Preparation and purification of AMcp AMcp were obtained by the tracheobronchial lavage method described fully elsewhere . Briefly, the lungs were washed with 5 ml of sterilized saline at 37°C. This process was repeated several times to obtain a total of 50ml of lavage fluid per rat. The total number of cells collected was determined by cell counts in a hemocytometer (using 2% acetic acid as diluent). The viability of nucleated cells suspended in PBS, measured by trypan blue dye exclusion, was >95%. More than 95% of the lavage cells from normal rats were AMq, judging by their positive staining for non-specific esterase. The remaining cells were small mononuclear cells or neutrophils, which were eliminated during washing of plated cells (see below). The lavage suspension was washed and resuspended in RPMI 1640 medium supplemented with 5% heat-inactivated foetal bovine serum (FBS), penicillin G, and streptomycin (named CRPMI 1640 medium), and 105 AM? were plated into wells of a Microtest II plate (Falcon Plastics, Oxnard, Calif.). Nonadherent cells (< 10%) were removed by washing the plate 60min after plating. At that time, >99% of the adherent cells were mononuclear and could phagocytize carbon particles.
In vitro activation of AMc
Inocula of 105 AMqp were plated and the resulting monolayers were washed 60 min later. Then they were incubated for 24 h with or without retinyl palmitate, muramyl dipeptide (MDP) (Calbiochem, La Jolla, CA) or lipopolysaccharide (LPS) (E. coli 055: B5 Difco Laboratories, Detroit, MI). The AM?p monolayers were then washed and assayed for AMqp-mediated cytotoxicity.
Assay of AMcp-mediated cytotoxicity in vitro
AMp-mediated cytotoxicity was assayed by measuring release of radioactivity as described in detail previously (Moriguchi et al., 1983; . After incubation for 2h at 37°C, the cultures were rinsed once for 10 sec with distilled water to lyse nonphagocytized SRBC and washed twice with PBS. The remaining adherent cells were lysed with 0.5N NaOH, and the lysate was monitored for radioactivity in a gamma counter. Values were obtained from data in triplicate cultures.
Statistical analysis
The statistical significance of differences between test groups was analyzed by Student's two-tailed ttest.
Results
In vitro activation of rat AM(p by vitamin A Rat AM? obtained from the lungs of normal F344 rats were plated for 1 h in CRPMI 1640, and then thoroughly washed and incubated for 24 h in medium with or without 5 pg ml -' LPS, 25kug ml -1 MDP, or various amounts of vitamin A. Then the AM? monolayers were washed and incubated with 2 x 104 MADB-100 cells for 72 h. AMp treated in vitro with 103-5 x103 IU retinyl palmitate showed much less tumoricidal activity (14-21%) than that of cells treated with LPS (72%) or with MDP (42%) ( Table I ). Phagocytic ability of vitamin A-treated rat AMp Male F344 rats of 5-7 weeks old were given saline, vitamin A placebo (soybean oil) or vitamin A (250 IU g-1 body wt) orally for 4 consecutive days, and 24 h later, their AMqp were harvested by lavage of the lungs. There was no difference in the numbers of AM(p obtained from the lungs of rats given saline, vitamin A placebo and vitamin A. The lavaged cells were plated for 60 min in CRPMI 1640 and then thoroughly washed to obtain a monolayer consisting of >99% AMp. The AM? monolayers in Costar 24 wells of 16mm diameter were tested for ability to phagocytize opsonized SRBC labelled with 51Cr. The combined data from 3 independent experiments are summarized in Figure 1 . AM? from rats that received >250 IU retinyl palmitate g-1 body wt showed significantly greater ability to phagocytize opsonized SRBC than those from rats given saline or vitamin A placebo alone.
In vivo activation of AMp by vitamin A Next we examined whether oral administration of vitamin A could render AM? tumoricidal. Rats were given saline, vitamin A placebo or 250 IU vitamin A orally for one or 4 days and 24 h after the last administration, their AMqp were lavaged and assayed for AMp-mediated cytotoxic activity. As shown in Figure 2 , administration of retinyl palmitate for 4 days resulted in significant and reproducible increase in AMq-mediated cytotoxicity against MADB-100. Dose response of AMcp to vitamin A in vivo F344 rats were given saline, vitamin A placebo or different amounts of vitamin A orally for 4 days. Twenty-four hours later, their AM? were lavaged and plated. The indicated numbers of MADB-100 cells were added to the AM(p monolayers and incubations were terminated 72h later. AMp from rats given vitamin A at 100-500 IU g-body wt acquired the ability to lyse syngeneic tumour cells in vitro. Under the same conditions, vitamin A placebo, a preparation consisting of soybean oil without vitamin A, did not render AM(p significantly cytotoxic (Table II) . In a parallel set of experiments, AMq, activated in vivo with vitamin A were incubated in CRPMI 1640, and at the indicated times, 1.5 x 104 labelled MADB-100 cells were added to the AMq monolayers. The tumoricidal activity of vitamin A-treated AM? was retained for 24-48 h, but was gradually lost by 96h after the start of culture (Figure 3) . at a dose of 250 IU g 1 body wt, and 24 h after the last dose, the AM? were lavaged and assayed for cytotoxic activity. Figure 4 shows that AMp from rats given retinyl palmitate, retinol or retinoic acid showed cytotoxic activity against syngeneic mammary adenocarcinoma cell lines (MADB-100 and MADB-200). Table   I show that noncytotoxic AM9 from rats can respond to a direct stimulus from retinyl palmitate in vitro to become tumoricidal. Vitamin A is known to affect tumour cell growth directly (Chopra & Wilkopf, 1976) . It is unlikely, however, that in the in vitro cytotoxicity assay used in this study, vitamin A inhibited tumour cell growth, since the AM9 monolayers were thoroughly washed to remove remaining vitamin A before the tumour target cells were added. This conclusion is also supported by the encouraging report that addition of a vitamin A analogue, such as retinol or retinoic acid, to cultures of human monocytes or guinea pig macrophages resulted in reduction in their Fc receptor functions but in enhancement of their enzyme production (Rhodes & Oliver, 1980 (Abb & Deinhard, 1980; Lapin et al., 1974; Micksche et al., 1977) , it is conceivable that when vitamin A was given orally the tumoricidal activity of AM? could be potentiated via vitamin A-stimulated lymphocytes. In any event, an increase by retinoids in the functions of both the monocyte-macrophage series and lymphocyte systems could account for the antitumour effects observed in vivo in transplanted tumour and carcinogenesis systems (Bollag, 1971 ; Kurata & Micksche, 1977; Moon et al., 1976; Nettesheim & Williams, 1976; Saffioti et al., 1967) .
We found that of three vitamin A analogues tested, all three retinoids (retinyl palmitate, retinol and retinoic acid) induced tumoricidal activity of rat AMp in vivo. The tumoricidal activity of AM? was significant when rats were given vitamin A orally for 4 days but not one day, suggesting that administration of vitamin A for 4 days was necessary for full activation of the tumoricidal activities of AM9 in vivo.
Large doses of vitamin A were necessary for in vivo activation of the tumoricidal activity of AM(p in the present work. However, the side effects of vitamin A seem to be less when it is given orally than when it is given i.p. or i.v. (Lapin et al., 1974; Seifter et al., 1983) . Since the lung is a frequent target organ for carcinogenesis and cancer metastasis in animals and humans, and there is increasing evidence in animals that activated AM(p are important in host defence against neoplasms in the lung Sone & Fidler, 1982) , the present work suggests that use of vitamin A to activate AM? in situ, in conjunction with other procedures, such as immunotherapy, chemotherapy and radiation therapy, might be of benefit in treatment of primary and/or metastatic cancer in the lung.
